1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
1200 Pharma has raised $2.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
1200 Pharma's investors include Kairos Ventures, Vest Coast Capital.
1200 Pharma is headquartered in Pasadena, United States.
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
1200 Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"1200 Pharma — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/1200-pharma. Accessed August 13, 2026.
VCBacked. (2024). 1200 Pharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/1200-pharma
{{cite web |title=1200 Pharma — Funding & Investors |url=https://www.vcbacked.co/company/1200-pharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated